Lee P. Shulman

Prof. Lee P. Shulman

Northwestern University, USA



1983 Ph.D., Cornell University Medical College, USA

1979 B.Sc., Cornell University, USA

Publications (selected)

  1. Nikolic D, Yuan Y, Wright B, Banuvar S, Shulman LP, Van Breemen RB. LC-MS analysis of prenylated flavonoids from hops in support of a Phase I clinical trial. American Society of Mass Spectrometry, Denver, CO, 2011.
  2. Shulman LP, Banuvar S, Fong HHS, Farnsworth NR (2010). Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC Center for Botanical Dietary Supplements Research Study of Black Cohosh and Red Clover. Fitoterapia, Oct 27 (epub ahead of print).
  3. Szarewski A, Mansour D, Shulman LP (2010). 50 years of “The Pill”: celebrating a golden anniversary. J Fam Plann Reprod Health Care, 36: 231-8.
  4. Shulman LP (2010).  Gynecological management of premenstrual symptoms. Curr Pain Headache Rep, DOI: 10.1007/s11916-010-0131-9.
  5. Freeman S, Shulman LP (2010). Considerations for the use of progestin-only contraceptives. J Am Acad Nurse Pract, 22: 81-91.
  6. Kiley J, Shulman LP (2009). Cesarean scar ectopic pregnancy in a patient with multiple prior cesarean sections: a case report. J Reprod Med, 54: 251-4.
  7. Kaunitz AM, Benrubi GI, Barbieri RL, Darney PD, Edelman A, Speroff L, Espey E, Shulman LP (2009). Ethics and referral for abortion (Letter to the Editor). Am J Obstet Gynecol, 200: e9.
  8. Maki PM, Rubin LH, Fornelli D, Drogos L, Banuvar S, Shulman LP, Geller SE.  Effects of botanicals and combined hormone therapy on cognition in midlife women. Menopause, Jul 31 epub.
  9. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, Hedayat S, Nikolic D, Krause EC, Piersen CE, Bolton JL, Pauli GF, Farnsworth NR (2009). Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopuase, Jul 15 epub.
  10. Bryant-Borders AE, Greenberg J, Plaga S, Shepard-Hinton M, Yates C, Elias S, Shulman LP (2009). Use of amniocentesis prior to uterine evacuation to increase the likelihood of obtaining cytogenetic outcomes in cases of second- and third-trimester fetal demise. Fetal Diagn Ther, 26: 81-4.
  11. van Breemen RB, Liang W, Banuvar S, Shulman LP, Pang Y, Tao Y, Nikolic D, Krock KM, Fabricant DS, Chen SN, Hedayat S, Bolton JL, Pauli GF, Piersen CE, Krause EC, Geller SE, Farnsworth NR. Pharmacokinetics of 23-Epi-26-Deoxyactein in women after oral administration of a standardized extract of Black Cohosh. Clin Pharmacol Ther, 2009 Dec 23. [Epub ahead of print].
  12. Grobman WA, Auger M, Shulman LP, Elias S (2009). The association between chorionic villus sampling and preeclampsia. Prenat Diagn, 29: 800–3.
  13. Shulman LP, Portman DJ, Lee WC, Balu S, Joshi AV, Cobden D, Wang Q, Pashos CL (2008). A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. Journal of Women’s Health, 17: 569-78.
  14. Hoffman ML, Scoccia B, Kurczynski TW, Shulman LP, Gao W (2008). Abnormal folate metabolism as a risk factor for first-trimester spontaneous abortion. J Reprod Med, 53(3): 207-12.
  15. Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE (2008). Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause, 15: 848-56.
  16. Bahamondes L, Cordova-Eguez S, Pons JE, Shulman L (2007). Perspectives on Premenstrual Syndrome.Premenstrual Dysphoric Disorder. Dis Manage Health Outcomes, 15: 263-77.
  17. Simon M, Shulman LP (2007). Alternatives to oral regimens of contraception. Minerva Ginecologica, 59: 271-86.
  18. Gabriel H, Shulman LP, Marko J, Nikolaidis P (2007). Compound versus fundamental imaging in the detection of subdermal contraceptive implants. J Ultrasound Med, 26: 355-9.
  19. Booth NL, Pierson CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR (2006). Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause, 13: 251-64.
  20. Shulman LP (2006). A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone. J Womens Health, 15: 584-90.
  21. Creinin M, Blumenthal P, Shulman L (2006). Mifepristone-Misoprostol Medical Abortion Mortality. Medscape General Medicine, 8(2): 26.
  22. Bonnick SL, Shulman L (2006). Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med, 119: 25S-31S.
  23. Shulman LP (2006). New recommendations for the periodic well-woman visit: impact on counseling. Contraception, 73: 319-24.
  24. Shulman LP, Gabriel H (2006). Management and localization strategies for the nonpalpable Implanon rod. Contraception, 73:325-30.
  25. Stewart FH, Kaunitz AM, LaGuardia KD, Karvois DL, Fisher AC, Friedman AJ and the ORTHO EVRA Extended Regimen Study Group (Shulman LP, member) (2005). Extended use of transdermal norelgestromin/ethinyl estradiol: A randomized trial. Obstetrics and Gynecology, 105: 1389–96.
  26. Shulman LP, Shields W (2005). The expanding role of genetics in contraception and women’s health. Contraception, 71: 81-3.